Status:
NOT_YET_RECRUITING
RHEUPP - A Rheumatological Follow-up Management App
Lead Sponsor:
Hospital de Clinicas de Porto Alegre
Collaborating Sponsors:
PANLAR - 2023 Innovation Award
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this Non-inferiority Randomized Clinical Trial is to evaluate the effectiveness of RHEUPP App during telehealth follow-up in a population of Rheumatoid Arthritis patients from a Tertiar...
Detailed Description
Participants with access to digital media will be sent a weblink for accessing the study's electronic questionnaires by electronic message or email, with a maximum interval of one week before or after...
Eligibility Criteria
Inclusion
- Adult patients (18y or older)
- Rheumatoid Arthritis according to the 2010 EULAR/ACR criteria
- Access to digital media (electronic messages, e-mail)
Exclusion
- Other rheumatological diseases (except Sjögren's Syndrome)
- Inability to understand the instrument in general or assistance from third parties (family member or caregiver) in carrying out the questionnaire at a disadvantage
- Incomplete information in data collection
- Patients with changes in their treatment in the last 4 weeks or treatment change plan at recruitment to the study.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
88 Patients enrolled
Trial Details
Trial ID
NCT06217172
Start Date
January 1 2024
End Date
December 1 2025
Last Update
January 22 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.